A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...

Tocilizumab treatments in patients with noninfectious uveitis demonstrated high rates of success at 1 year follow ups.

IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance ...

Case reports and studies have shown a direct correlation between increased ICP and sodium nitroprusside infusion. [43–45] Information regarding the effect of sodium nitroprusside on cerebral ...

Jet lag is a common travel nuisance that can turn an exciting journey into an exhausting ordeal. It occurs when there’s a mismatch between your internal body clock and the new time zone you’re in.

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

DNR indicates do not resuscitate; IO, intraosseous; and IV, intravenous. The study conducted an investigation categorizing patients into intravenous and intraosseous groups either from upper or lower ...

GRCE READ THE FULL GRCE RESEARCH REPORT We are initiating coverage of Grace Therapeutics, Inc. (NASDAQ:GRCE) with a valuation of $12.50 per share. This value is based on our estimates for the successf ...

Get the facts on cost and allopurinol, how generics compare with brand names, what financial assistance may be available, and ...